How it works
Raw news to ranked stories
in seconds.
Every article is categorized and scored so the news most likely to move a stock surfaces first — instead of getting buried under press releases and opinion pieces.
The pipeline
Three steps from raw feed to ranked feed
1. Pull the news
We stream financial news from Polygon.io, the same institutional-grade data feed used by hedge funds and trading desks. Every article is deduplicated and normalized in real time.
2. Identify the event type
Each article is scanned for the type of news it contains — FDA decisions, earnings results, mergers, analyst upgrades, insider buying, and 15+ other categories. These are the events most likely to move a stock price, so knowing the type helps you decide instantly if a story is relevant to you.
3. Score by importance
Every article gets scored across four factors: source quality, news category, AI sentiment, and recency. The highest-scoring stories surface first — automatically, before you open the app.
Scoring
What makes a story rank higher
Each article is scored across four factors. The scores are never shown to you — they just determine what floats to the top.
Source quality
Wire services and established financial publishers outrank opinion blogs and aggregators. Articles from major news publishers score higher; commentary-heavy or low-authority sources score lower.
Catalyst type
An FDA approval outranks an analyst note. Earnings beats and Phase 3 results outrank routine press releases. The event type matters more than the source.
Market sentiment
Articles with a clear positive or negative signal score higher than neutral commentary. Drawn from the Polygon.io sentiment API.
Recency
A story published 30 minutes ago scores higher than the same story from yesterday. Breaking news gets a significant recency boost.
Categories
20+ event types, all tagged automatically
These categories cover the events that historically move stocks — so you can filter to exactly what you care about.
FDA regulatory action: approval, rejection, PDUFA date, or breakthrough designation
Clinical trial results:phase data, endpoint outcomes, or trial milestones
Earnings report: beat/miss, revenue, EPS, or guidance changes
Merger or acquisition:buyout, takeover, or merger agreement
Strategic partnership:collaboration, joint venture, or licensing deal
Patent activity:grant, infringement, or IP dispute
Analyst action: upgrade, downgrade, or price target change
Government or regulatory action:SEC, DOJ, FTC, or compliance issue
Class action or securities fraud lawsuit filed against the company
Insider trading activity:executive buying or selling shares
Major product launch or commercial availability announcement
Dividend initiation, increase, cut, suspension, or special dividend declaration
Share issuance events: secondary offering, ATM program, stock split, reverse split, spin-off, or lockup expiration
Share repurchase program announcement or accelerated buyback
Executive leadership change, board appointment, activist investor involvement, or major workforce restructuring
Stock added to or removed from a major index like S&P 500 or Russell 2000
Credit rating change, bankruptcy filing, debt restructuring, or bond issuance
Government or major commercial contract win, award, or loss
Product recall, safety warning, or major operational disruption
Operational milestone: first flight, certification, first delivery, or major product demonstration
Federal Reserve decisions, inflation data, jobs reports, or other market-wide economic events
High-signal market structure event: trading halt, fraud, restatement, bankruptcy, delisting, or strategic alternative
Ready to stop missing the news that matters?
Get started free. No credit card required.
Get Started Free